Ursodeoxycholic acid during treatment for Barrett's esophagus
Part of Cancer, Digestive system clinical trials.
This study tests whether taking a bile acid pill (ursodeoxycholic acid) during treatment for Barrett's esophagus can help the esophagus heal better after standard endoscopic therapy. It may reduce the chance of precancerous cells returning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have Barrett's esophagus (a change in the lining of your food pipe) confirmed by biopsy.
- The biopsy must show abnormal cells (dysplasia) or very early cancer in that tissue.
- The Barrett's area must be at least 2 centimeters long.
- If you've had a prior endoscopic ablation (a treatment that removes abnormal cells with heat or cold), you can join only if you had just one and it reduced the Barrett's area by less than half.
- You must be able to take the study drug, ursodeoxycholic acid (a bile acid pill), twice a day.
- You must not be pregnant or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two approaches for people with Barrett's esophagus and low-grade dysplasia: regular surveillance (monitoring with endoscopies) versus endoscopic treatment to remove the abnormal cells. It aims to see which approach is better at preventing progression to more serious conditions.
This study tests a new, less invasive way to collect cells from the esophagus using a small sponge on a string (called Cytosponge). It aims to see if this method can accurately detect Barrett's esophagus, a condition that can raise the risk of esophageal cancer.
This study follows people for 5 years to see how well a new biopsy-mapping test (WATS3D) works during routine upper endoscopy. It may help doctors find Barrett’s esophagus changes earlier and better guide follow-up after treatment.
This Phase 2 trial tests whether obeticholic acid (a medicine) can help stop Barrett’s esophagus from getting worse. You must already be taking acid-suppressing medicine and have non-cancer Barrett’s changes, and the study checks safety and whether the lining improves or stays stable.
This trial tests a newer, stronger type of acid-reducing pill (called a PCAB) to see if it controls acid better than the usual medicines for people with Barrett's esophagus. The goal is to reduce acid exposure that can lead to further damage.
This trial tests if ursodeoxycholic acid can reverse intestinal metaplasia (a precancerous stomach condition) in patients who have no H. pylori infection. The goal is to see if this medication can help lower the risk of stomach cancer.
Hear when a new Barretts Esophagus With Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.